Abstract
On 17 May, Claude Lenfant, director of the National Heart, Lung, and Blood Institute (NHLBI), declared an end to the decades-long controversy over salt, blood pressure, and public health. The results of DASH-Sodium, a new NHLBI-funded study to be presented the next day at the annual meeting of the American Society of Hypertension, had made the health benefits of salt reduction unambiguous, Lenfant said. After the meeting, the controversy showed little sign of abating, however.

This publication has 0 references indexed in Scilit: